ESMA - Annual Report on the application of waivers and deferrals under MiFID II

The report includes an analysis based on waiver applications received in the course of the 2017 and 2018 and for which ESMA issued an opinion to the competent authority (CA) before 31 December 2018. It also includes an overview of the deferral regimes applied across the different Member States distinguishing between on-venue and OTC application.

The Annual Report analyses the application of:

·         equity waivers;

·         the deferral regime to equity instruments;

·         non-equity waivers; and

·         the deferral regime to non-equity instruments.

ESMA will publish its next annual report in 2020.